Llwytho...
T-Cell Prolymphocytic Leukemia: An Overview of Current and Future Approaches
T-cell prolymphocytic leukemia (T-PLL) is a rare mature T-cell hematologic neoplasm with a very poor prognosis and limited treatment options to date. Single-agent alemtuzumab remains the first line of therapy for the treatment-naive and relapsed/refractory patients. Prospective clinical trials are d...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Cureus |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Cureus
2021
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7948687/ https://ncbi.nlm.nih.gov/pubmed/33728186 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.13237 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|